Keywords: ریواروکسابان; NOAC; Rivaroxaban; NOAC induced haematoma; Upper limb; Haematoma;
مقالات ISI ریواروکسابان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ریواروکسابان; Dabigatran; Rivaroxaban; Apixaban; Atrial fibrillation; Cancer; Anticoagulants;
Keywords: ریواروکسابان; Type 2 diabetes; Direct oral anticoagulants levels; Dabigatran; Rivaroxaban; Apixaban; Hemoclot® Thrombin Inhibitor Assay; Atrial fibrillation;
Keywords: ریواروکسابان; Apixaban; Aspirin; Bleeding; Dabigatran; Direct-acting oral anticoagulant; Gastrointestinal; Hospitalization; Intervention; Mortality; Rivaroxaban; Severity; Transfusion; Warfarin;
Keywords: ریواروکسابان; Stroke; dabigatran; rivaroxaban; apixaban; edoxaban; oral anticoagulants;
Keywords: ریواروکسابان; Photolysis; Solar light irradiation; Surface water; Apixaban; Dabigatran; Rivaroxaban;
Keywords: ریواروکسابان; Deep Vein Thrombosis; Anticoagulant drugs; Thrombolytic therapy; Mechanical thrombolysis; Rivaroxaban; Apixaban; Edoxaban; Dabigatran; Warfarin;
Keywords: ریواروکسابان; Traumatic brain injury (TBI); Mortality; Morbidity; Rivaroxaban; Anticoagulant; Phenprocoumon;
Keywords: ریواروکسابان; PT; prothrombin time; PT-INR; prothrombin time-international normalized ratio; APTT; activated partial thromboplastin time; CT; computed tomography; IVR; interventional radiography; LCA; left colic artery; SRA; superior rectal artery; DOAC; direct oral an
Keywords: ریواروکسابان; Magnetic nanoparticles; Thermosensitive polymer; Dendrimers; Rivaroxaban; Human biological fluid;
Keywords: ریواروکسابان; dabigatran; direct oral anticoagulants; rivaroxaban; spontaneous spinal hematoma;
Keywords: ریواروکسابان; Antiplatelet drugs; apixaban; bleeding; dabigatran; direct oral anticoagulants; disseminated intravascular coagulation; edoxaban; liver disease; rivaroxaban; vascular abnormalities; vitamin K deficiency; warfarin;
Keywords: ریواروکسابان; Antiphospholipid syndrome; Direct oral anticoagulants; Rivaroxaban; Apixaban; Dabigatran; Thrombosis;
Keywords: ریواروکسابان; Novel oral anticoagulants; Dabigatran; Rivaroxaban; Apixaban; New oral anticoagulants use assessment;
Keywords: ریواروکسابان; Lupus anticoagulant; New oral anticoagulants; Antiphospholipid syndrome; Rivaroxaban; Dabigatran;
Keywords: ریواروکسابان; Canine; Anticoagulant; Rivaroxaban; Thromboelastography;
Keywords: ریواروکسابان; Apixaban; Dabigatran; DOACs; Edoxaban; Measurement; Reversal; Rivaroxaban;
Keywords: ریواروکسابان; Absorption; Anticoagulation; Apixaban; Bariatric surgery; Biliopancreatic diversion; Bleeding; Dabigatran; Edoxaban; Efficacy; Gastrectomy; Gastric banding; Obesity; Pharmacokinetics; Rivaroxaban; Roux-en-Y; Safety; Thrombosis; Warfarin;
Keywords: ریواروکسابان; Fibrilación auricular no valvular; Práctica clÃnica; Pacientes de la vida real; Rivaroxaban; ROCKET-AF; Registro; Nonvalvular atrial fibrillation; Clinical practice; Real-life patients; Rivaroxaban; ROCKET-AF; Registry;
Keywords: ریواروکسابان; Anticoagulants; Bariatric surgery; Obesity; Rivaroxaban; Thromboprophylaxis;
Keywords: ریواروکسابان; Direct oral anticoagulant; Dabigatran; Rivaroxaban; Apixaban; Edoxaban; Randomized clinical trials;
Keywords: ریواروکسابان; Solubility; Polymorph; Rivaroxaban; Measurement; Thermodynamic modelling;
Keywords: ریواروکسابان; cost burden; hospital-acquired complications; pulmonary embolism; rivaroxaban;
Keywords: ریواروکسابان; Atrial fibrillation; Vitamin K antagonists; Dabigatran; Rivaroxaban; Apixaban;
Keywords: ریواروکسابان; rivaroxaban; thromboprophylaxis; periprosthetic joint infection; total hip arthroplasty; total knee arthroplasty
Keywords: ریواروکسابان; Rivaroxaban; Venous thromboembolism; Treatment outcome; Safety; Extremes of body weight;
Keywords: ریواروکسابان; Dabigatran; Rivaroxaban; Bleeding; Atrial fibrillation; Non-vitamin K oral antagonists
Keywords: ریواروکسابان; apixaban; dabigatran; postoperative bleeding; rivaroxaban; tooth extraction
Keywords: ریواروکسابان; Idarucizumab; Andexanet alfa; DOAC; NOAC; Dabigatran; Rivaroxaban; Apixaban; Edoxaban; Antidote; Praxbind; ANNEXA-A; ANNEXA-R;
Keywords: ریواروکسابان; Apixaban; Dabigatran; Direct thrombin inhibitors; Edoxaban; Factor Xa inhibitors; Rivaroxaban;
Keywords: ریواروکسابان; Dabigatran; Rivaroxaban; Apixaban; Warfarin; Praxbind; Factor Xa inhibitors; Andexanet alfa;
Keywords: ریواروکسابان; Atrial fibrillation; Circadian variation; Coagulation assay; Rivaroxaban; Warfarin;
Keywords: ریواروکسابان; Apixaban; Bleeding management; Clinical trials; Dabigatran; Direct oral anticoagulants; Edoxaban; Rivaroxaban;
Keywords: ریواروکسابان; Anticoagulación oral; Fibrilación auricular; Dabigatran; Rivaroxaban; Apixaban; Edoxaban;
Keywords: ریواروکسابان; Anticoagulation; Novel oral anticoagulants; Rivaroxaban; Apixaban; Edoxaban; Dabigatran
Keywords: ریواروکسابان; Intracranial hemorrhage; Cerebral bleeding; Anticoagulants; Warfarin; Rivaroxaban; Apixaban; Dabigatran
Keywords: ریواروکسابان; Anticoagulanti; Dabigatran; Rivaroxaban; Sanguinamento; Chirurgia orale; Anticoagulants; Dabigatran; Rivaroxaban; Bleeding; Oral surgery;
Keywords: ریواروکسابان; Thrombophrophylaxis; Rivaroxaban; Apixaban; Total hip arthroplasty; Total knee arthroplasty; NOAC; Venous thromboembolism (VTE);
Keywords: ریواروکسابان; anticoagulation; emergency medicine; rivaroxaban; venous thromboembolism;
Keywords: ریواروکسابان; adherence; anticoagulant; apixaban; atrial fibrillation; rivaroxaban;
Keywords: ریواروکسابان; Dabigatran; Intracerebral hemorrhage; Intracranial hemorrhage; Neurosurgical treatment; New target specific oral anticoagulants; Rivaroxaban; CT; Computed tomography; GCS; Glasgow Coma Scale; PCC; Prothrombin complex concentrate; INR; International normal
Keywords: ریواروکسابان; LC-MS/MS; Direct oral anticoagulants; Coagulation tests; Chromogenic assay; Rivaroxaban; Edoxaban; Apixaban; Dabigatran;
Keywords: ریواروکسابان; Rivaroxaban; Anticoagulant; Thromboembolism
Keywords: ریواروکسابان; Apixaban; Dabigatran; Intracranial hemorrhages; Rivaroxaban; Treatment outcome
Keywords: ریواروکسابان; Novel anticoagulants; Bleeding; Vitamin K antagonists; Dabigatran; Rivaroxaban; Atrial fibrillation
Keywords: ریواروکسابان; Transcranial Doppler ultrasonography; dabigatran etexilate; warfarin; rivaroxaban; embolus; middle cerebral artery
Keywords: ریواروکسابان; warfarin; anticoagulation; dabigatran; rivaroxaban; apixaban;
Keywords: ریواروکسابان; Acute lung hemorrhage; Anticoagulation therapy; Xarelto®; Rivaroxaban
Keywords: ریواروکسابان; anticoagulation; apixaban; cutaneous surgery; dabigatran; novel drugs; rivaroxaban; warfarinCYP3A4, cytochrome P450 3A4; NOAC, novel oral anticoagulant; P-gp, permeability glycoprotein
Keywords: ریواروکسابان; Tromboembolismo venoso; Dabigatrán; Rivaroxabán; Apixabán; EdoxabánVenous thromboembolism; Dabigatran; Rivaroxaban; Apixaban; Edoxaban